Clinical Research Directory

Kinesio Taping for Pain, Median Nerve Morphology, and Quality of Life in Patients With Carpal Tunnel Syndrome

Carpal tunnel syndrome is a common condition caused by compression of the median nerve at the wrist. It can result in pain, numbness, tingling, weakness, and difficulty performing daily activities. Conservative treatments, including therapeutic exercises and kinesio taping, are frequently used; however, evidence regarding the effects of kinesio taping on both nerve morphology and clinical outcomes remains limited. The purpose of this randomized controlled trial is to evaluate whether adding kinesio taping to a standard exercise program provides greater benefits than exercise alone in patients with carpal tunnel syndrome. Participants will be randomly assigned to one of two groups: an intervention group receiving kinesio taping plus nerve and tendon gliding exercises, or a control group receiving the exercise program alone. Outcome measures include ultrasonographic assessment of the median nerve anteroposterior and transverse diameters, pain intensity measured with the Visual Analog Scale (VAS), and symptom severity and functional status evaluated using the Boston Carpal Tunnel Questionnaire. Assessments will be performed before treatment and after the 4-week intervention period. The findings of this study are expected to provide evidence regarding the effectiveness of kinesio taping as an adjunct to conservative rehabilitation for individuals with carpal tunnel syndrome and may contribute to improving treatment strategies for this condition.

Ultrasound-Guided Nerve Hydrodissection for Diabetic Lower Limb Entrapment Neuropathy

The goal of this clinical trial is to learn if a single session of ultrasound-guided nerve hydrodissection can relieve symptoms of diabetic lower limb entrapment neuropathy, a condition caused by compressed nerves in the leg that leads to numbness, pain, or muscle weakness in people with diabetes. The main questions it aims to answer are whether nerve hydrodissection improves nerve function (measured by the Toronto Clinical Scoring System) one month after treatment, and whether it relieves pain and improves quality of life. Researchers will compare two groups: one will receive the actual nerve hydrodissection (injection of medicine around the compressed nerve), and the other will receive a sham procedure that involves injecting a small amount of fluid under the skin (not around the nerve). Participants will not know which group they are in, and the researchers who measure the results will also not know. Participants will have four in-person visits over about one month, complete questionnaires about their nerve symptoms, pain, and quality of life, undergo nerve ultrasound at the beginning and at follow-up visits (at 1 month after treatment), and receive either the nerve hydrodissection or the sham procedure at the second visit. All participants will continue their regular diabetes and nerve medication during the study.